Showing results (831-840 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|July 5, 2024
Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction-associated steatotic liver diseaseDavid E Kaplan, Craig C Teerlink, Tae-Hwi Schwantes-An, et al.
Hepatology Communications|July 5, 2024
Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal contextAdrien Guillot, Frank Tacke
Hepatology Communications|April 2, 2024
Complementary and alternative medicines and liver diseaseCyriac Abby Philips, Arif Hussain Theruvath, Resmi Ravindran, et al.
Hepatology Communications|April 4, 2024
Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathwayLiangbo Sun, Meng He, Feng Li, et al.
Hepatology Communications|January 29, 2024
Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: A systematic reviewMohammad Alsaeid, Shuen Sung, Wayne Bai, et al.
Hepatology Communications|January 29, 2024
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastomaSalih Demir, Negin Razizadeh, Emilie Indersie, et al.
Hepatology Communications|January 29, 2024
Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastomaRuhi Gulati, Maggie Lutz, Margaret Hanlon, et al.
Hepatology Communications|January 22, 2024
Management of alcohol withdrawal syndrome in patients with alcohol-associated liver diseaseJessica A Ratner, Hanna Blaney, Darius A Rastegar
Hepatology Communications|August 26, 2024
Genetic variants associated with immune-mediated liver injury from checkpoint inhibitorsRobert J Fontana, Yi-Ju Li, Vincent Chen, et al.
Hepatology Communications|August 26, 2024
Sex- and age-associated factors drive the pathophysiology of MASLDAjay K Yadav, Justin J MacNeill, Aleksei Krylov, et al.
Pageof 179